Business Wire

Desktop Metal Qualifies Sterling Silver on the Production System, Cementing Additive Manufacturing Leadership in Jewelry Industry

7.6.2022 11:01:00 EEST | Business Wire | Press release

Share

Desktop Metal (NYSE: DM) today announced that 925 sterling silver, a popular precious metal, is now qualified for 3D printing on the Production System™ platform, including both the P-1 and P-50, offering jewelry and luxury goods manufacturers the fastest way to directly 3D print high-quality jewelry, watches, belt buckles, and decorative hardware for handbags.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220606005677/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Exquisite sterling silver chevron stacking rings designed by Christian Tse and 3D printed on the Desktop Metal Production System P-1. The Production System now offers jewelry and luxury goods manufacturers the fastest way to directly 3D print high-quality sterling silver jewelry, watches, belt buckles, and decorative hardware for handbags. (Photo: Business Wire)

Desktop Metal is also fast-tracking the development of additional precious metal alloys in 2022, including 18K yellow gold, with active research and development underway on rose gold. Desktop Metal and its ETEC polymer brand have a longtime history of partnering with major jewelry producers around the world such as Cartier, Stuller, Shinola and Swarovski.

“The qualification of precious metals for direct 3D printing on high-speed binder jetting systems is a major milestone for the jewelry and luxury goods industry,” said Ric Fulop, Founder and CEO of Desktop Metal. “All the design freedom and customization of 3D printing can now be delivered directly at high volumes without all of the labor associated with traditional manufacturing processes. What’s more, this new direct 3D printing innovation builds on the established legacy of our ETEC brand, which has been a leader in 3D printers for lost-wax casting models for more than a decade — making us the unparalleled leader in comprehensive additive manufacturing solutions for the jewelry and luxury goods market.”

Partnerships to Advance Technology and Materials Development

To advance the technology and materials needed to bring world-class 3D printing quality, productivity, and economics to the demanding luxury goods and jewelry market, Desktop Metal is partnering with two leaders in precious metals powder and parts production: Formula 3D Corporation founded by Christian Tse of Christian Tse Designs & Manufacturing Inc. for the U.S. market, and Neoshapes for international clientele. Both of these collaborations aim to enable the luxury goods and jewelry markets to adopt metal binder jetting processes to produce end-use parts in precious metals, steels, and more.

Formula 3D Corporation offers designers and manufacturers a complete end-to-end solution for 3D printing precious metals — from the design to beautiful, customer-ready finished quality jewelry. A new video released with Christian Tse showcases how this Monrovia, California-based luxury design and manufacturing house is using the Desktop Metal Production System P-1 to reimagine its jewelry manufacturing.

“Desktop Metal’s Production System adds extraordinary value to our existing jewelry manufacturing processes, increasing efficiency of production, getting new designs to market faster, and offering our customers greater versatility and multiple styling options. We can actually print in precious metals in two hours what we do in two days with casting,” said Christian Tse. “In addition, creating jewelry with binder jetting is allowing us to consider new options to circumvent some of the supply chain challenges facing the fine jewelry industry. We can bypass shipping delays and mounting costs, as well as avoid duties, by printing the precious silver directly, as opposed to shipping the physical metal.”

Neoshapes, a Swiss company based in Geneva, Switzerland, founded by experienced executives in the luxury goods industry, takes a unique end-to-end approach — from the production and supply of powder, to the printing and post-processing of precious metals components, as well as consultancy services to enable industry players to easily transition their production processes to binder jet technology.

“Binder jetting opens up new perspectives for the luxury industry, even more now with the qualification of precious metal alloys, giving further leverage to develop and produce creative products from a single file, leaping forward into the digital supply chain. The time to market for new creative products is also reduced considerably, allowing brands to better meet demand while maintaining minimal inventories,” said Stéphane Vigié, Neoshapes co-founder.

Binder Jetting Ushers in a New Era for Jewelry Manufacturing

The Production System’s Single Pass Jetting™ (SPJ) technology, which delivers high-speed 3D printing of metals, enables jewelers to adopt an entirely digital and agile manufacturing workflow. Jewelers can have greater design flexibility and control, allowing designers and manufacturers to scale new designs previously impossible or difficult to produce without significant manual labor — such as chain link bracelets or necklaces, where the links can be 3D printed in place as one piece instead of being manually assembled one link at a time. In addition, jewelers can leverage AM for localized production, decreasing the reliance on long lead-time global supply chains and offering opportunities for onshoring manufacturing.

The benefits of additive manufacturing for luxury goods and jewelry applications are significant:

- Customization and Design Freedom at High Volumes
Up to tens of thousands of jewelry pieces per day can be 3D printed on the Production System, and manufacturers can produce the same pieces or customized, unique ones — all in a single build.

- Digital Inventory Offers Greater Production Flexibility
By eliminating time-intensive techniques like casting, manufacturers can iterate and scale new designs easily — once a design is finalized, printing and production can begin immediately. Manufacturers can also establish digital inventories, storing design files digitally to be made on demand, reducing working capital requirements.

- Significant Reduction in Waste Material through Recycling and Reuse
With the Production System, substantially all of the loose powder recovered during the printing and depowdering process can be recycled and reused for subsequent prints, driving further cost efficiencies and reducing material waste.

World’s Fastest Way to 3D Print Sterling Silver Jewelry on Display at JCK Show

Exquisite jewelry designs from Christian Tse printed in sterling silver on the Production System will be on display June 10-13 in Las Vegas at the 2022 JCK Show, a leading jewelry event in North America, at stand #52025. In addition, Desktop Metal will exhibit affordable solutions for jewelry casting, including the ETEC D4K printer, a high-resolution professional-grade desktop 3D printer, suitable for end-use applications, dental, and jewelry.

To learn more about the Production System and printing in precious metals, visit: www.desktopmetal.com/production.

About Desktop Metal

Desktop Metal, Inc., based in Burlington, Massachusetts, is accelerating the transformation of manufacturing with an expansive portfolio of 3D printing solutions, from rapid prototyping to mass production. Founded in 2015 by leaders in advanced manufacturing, metallurgy, and robotics, the company is addressing the unmet challenges of speed, cost, and quality to make additive manufacturing an essential tool for engineers and manufacturers around the world. Desktop Metal was selected as one of the world’s 30 most promising Technology Pioneers by the World Economic Forum, named to MIT Technology Review’s list of 50 Smartest Companies, and the 2021 winner of Fast Company’s Innovation by Design Award in materials and Fast Company’s Next Big Things in Tech Award for sustainability. For more information, visit www.desktopmetal.com.

About Formula 3D Corporation

Founded in 2019 by Christian Tse, Formula 3D Corporation is an additive manufacturing company focused on precious metals, supplying 3D printing products and solutions for the fine jewelry, dental, medical, and space travel industries. Based in Monrovia, CA, Formula 3D aims to revolutionize the US manufacturing industry by providing access to a full ecosystem of 3D precious metal manufacturing services and products, including atomized powders, 3D printing, touchless finishing, and metal alloys. www.formula3Dcorp.com.

About Neoshapes®

With extensive experience in Additive Manufacturing to serve the luxury industry, Neoshapes is the first integrated specialist dedicated to 3D printing for the global luxury goods sector. With a strong focus on precious metals, Neoshapes proposes a full range of turnkey solutions that ensure increased efficiency and superior quality excellence for its Partner Brands. Neoshapes was established to respond to the ever-evolving needs of the luxury industry, specifically a more personalized connection to consumers with services such as production-on-demand, limited editions, customization, and special orders – growing trends that currently are not well served by traditional manufacturing methods. Based in Geneva, Switzerland, Neoshapes is fully committed to luxury goods 3D printing with core competencies in precious metals, from traceability of materials, through to alloying, powdering, printing, finishing, and traceability of finished products, all under one roof.

Forward-looking Statements

This press release contains certain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks, uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to, the risks and uncertainties set forth in Desktop Metal, Inc.'s filings with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Desktop Metal, Inc. assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Relations:
Desktop Metal Contact
Lynda McKinney
lyndamckinney@desktopmetal.com
(978) 224-1282

Christian Tse Contact
Duvall O’Steen
duvall@luxbrandgroup.com
(917) 363-3724

Neoshapes Contact
Gautier Mougel
gautier.mougel@Neoshapes.com
+41 76 817 85 45

Investor Relations:
Jay Gentzkow
jaygentzkow@desktopmetal.com
(781) 730-2110

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye